Skip to main content

Fulcrum Asset Management LLP

Position in ZTS — Zoetis Inc.

CIK 1353395 LONDON, X0

Position in ZTS

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$223,772
-$144,333 QoQ
Shares Held
3,114
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,014
of 1,408 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Mar 31, 2025
CallValue
$0
CallShares
0
PutValue
$410,801
PutShares
2,495

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Fulcrum Asset Management LLP holds $360,293 across 9 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (62.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
This page
3,114 $223,772

All Filings in ZTS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $223,772 3,114
2026-03-31 $368,105 3,114
2025-12-31 $391,803 3,114
2025-09-30 $388,772 2,657
2025-06-30 $414,359 2,657
2025-03-31 $410,801 2,495
2024-12-31 $408,139 2,505
2024-09-30 $489,036 2,503
2022-03-31 $4,877,503 25,863
2021-12-31 $2,709,953 11,105
2021-09-30 $2,155,924 11,105
2021-03-31 $1,469,130 9,329
2020-12-31 $9,267,834 55,999
2020-06-30 $7,674,102 55,999